BECTON

Outcome Capital Continues to Expand with the Addition of Industry Veteran Stanislav Glezer, MD MBA

Retrieved on: 
Tuesday, May 7, 2024
Professional Services, Health, Medical Devices, Other Health, Other Science, Finance, Science, University, California Coast University, BD (company), Real, Capital, Dentistry, Certification, Publication, Columbia Business School, MD, Doctor of Philosophy, McGill University, Novo Nordisk, Worldwide, MDR, MBA

Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm today announced that Stanislav Glezer, MD MBA, has been appointed to the role of Managing Director.

Key Points: 
  • Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm today announced that Stanislav Glezer, MD MBA, has been appointed to the role of Managing Director.
  • Oded Ben-Joseph, PhD, MBA, Outcome’s Managing Partner commented, “On behalf of the Outcome Capital team, I congratulate Stan on this appointment as I am confident that he will be a tremendous asset to our firm and to our clients.
  • “This role is well aligned with my personal mission of improving patients’ outcomes through innovation.
  • Prior to joining Becton Dickinson, Dr. Glezer served as the Chief Medical Officer at Adocia S.A. and as Vice President of Global Medical Affairs at Novo Nordisk, Inc.

Pharmaceutical Packaging Market to Be Worth $176.54 Billion by 2031 - Exclusive Report by Meticulous Research®

Retrieved on: 
Friday, May 3, 2024
PFS, United Nations, Polyvinyl chloride, Investment, PP, Ampoule, PVC, Polymer, Medicine, Paper, AptarGroup, Gas, Sachet, Blister, Drug discovery, PET, Inhaler, Catalent, Drug packaging, Cellulose, Tablet, Corning Inc., Regulation (European Union), Conditional sentence, Research, Transport, Carbon, QR, Shield, Government, WestRock, Polyethylene, Capsule, Syringe, Glass, Route of administration, Environment, United, Amcor, Growth, Fine chemical

Pharmaceutical companies are increasingly focusing on sustainable pharmaceutical packaging in order to cut waste and reduce their carbon footprint.

Key Points: 
  • Pharmaceutical companies are increasingly focusing on sustainable pharmaceutical packaging in order to cut waste and reduce their carbon footprint.
  • Key findings in the pharmaceutical packaging market report:
    Among all the materials studied in this report, in 2024, the polymer segment is expected to account for the largest share of 43% of the pharmaceutical packaging market.
  • Among all the packaging types studied in this report, in 2024, the primary packaging segment is expected to account for the largest share of 72% the pharmaceutical packaging market.
  • However, Asia-Pacific pharmaceutical packaging market is expected to growth with the highest CAGR of 8.5% over the forecast period.

Pharmaceutical Packaging Market to Be Worth $176.54 Billion by 2031 - Exclusive Report by Meticulous Research®

Retrieved on: 
Friday, May 3, 2024
PFS, United Nations, Polyvinyl chloride, Investment, PP, Ampoule, PVC, Polymer, Medicine, Paper, AptarGroup, Gas, Sachet, Blister, Drug discovery, PET, Inhaler, Catalent, Drug packaging, Cellulose, Tablet, Corning Inc., Regulation (European Union), Conditional sentence, Research, Transport, Carbon, QR, Shield, Government, WestRock, Polyethylene, Capsule, Syringe, Glass, Route of administration, Environment, United, Amcor, Growth, Fine chemical

Pharmaceutical companies are increasingly focusing on sustainable pharmaceutical packaging in order to cut waste and reduce their carbon footprint.

Key Points: 
  • Pharmaceutical companies are increasingly focusing on sustainable pharmaceutical packaging in order to cut waste and reduce their carbon footprint.
  • Key findings in the pharmaceutical packaging market report:
    Among all the materials studied in this report, in 2024, the polymer segment is expected to account for the largest share of 43% of the pharmaceutical packaging market.
  • Among all the packaging types studied in this report, in 2024, the primary packaging segment is expected to account for the largest share of 72% the pharmaceutical packaging market.
  • However, Asia-Pacific pharmaceutical packaging market is expected to growth with the highest CAGR of 8.5% over the forecast period.

BD to Present at Bank of America Securities Health Care Conference 2024

Retrieved on: 
Monday, April 29, 2024
BDX, Bank, Conference

FRANKLIN LAKES, N.J., April 29, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024 at 11:00 am Eastern Time.

Key Points: 
  • FRANKLIN LAKES, N.J., April 29, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024 at 11:00 am Eastern Time.
  • The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com .
  • A replay of the event will be available on the same webpage following its conclusion.

Babson Diagnostics Develops Hand-Warming Device to Support Collection of High-Quality Capillary Blood Samples

Retrieved on: 
Tuesday, April 16, 2024
Health, Medical Devices, Biometrics, Health Technology, Research, Science, Biotechnology, FDA, University, Pharmacy, Blood, Food, Finger, Biomedical engineering, Hand, Partnership, Collection, Biomedicine, Babson, Diagnosis, Patient, Multimedia, Student, Moses Austin, Medical device

The company created a unique hand-warming technology specifically designed to support the collection of high-quality blood samples from a fingertip.

Key Points: 
  • The company created a unique hand-warming technology specifically designed to support the collection of high-quality blood samples from a fingertip.
  • View the full release here: https://www.businesswire.com/news/home/20240416592258/en/
    Collection on Babson Handwarmer (Photo: Business Wire)
    Warming the hand is a common way to aid blood collection from a fingertip.
  • The device received overwhelmingly positive feedback from pharmacy staff trained as collection techs and the customers getting a BetterWay blood test.
  • The Babson Hand Warmer is listed as a Class II medical device with the FDA, and Babson Diagnostics is licensed as a medical device manufacturer and distributor in Texas.

Collective Healthcare Action to Reduce MedTech Emissions (CHARME) tackles emissions-intensive health care supply chain

Retrieved on: 
Tuesday, April 9, 2024
Health, Organization, Partnership, Cardinal Health, Hospital, Transport, Northwell Health, Accenture, Interim, Kaiser Permanente, Environmental health, Medtech, Renewable energy

OAKLAND, Calif., April 9, 2024 /PRNewswire/ -- The Collective Healthcare Action to Reduce MedTech Emissions (CHARME) collaborative launched today with the goal of reducing greenhouse gas emissions that arise from the multi-billion dollar U.S. medical device and equipment supply chain.  The MedTech (medical device, equipment, service, and distribution) supply chain accounts for 7% of U.S. health care greenhouse gas emissions. The Sustainable Purchasing Leadership Council is leading this effort in partnership with Kaiser Permanente and Vizient.

Key Points: 
  • OAKLAND, Calif., April 9, 2024 /PRNewswire/ -- The Collective Healthcare Action to Reduce MedTech Emissions (CHARME) collaborative launched today with the goal of reducing greenhouse gas emissions that arise from the multi-billion dollar U.S. medical device and equipment supply chain.
  • The MedTech (medical device, equipment, service, and distribution) supply chain accounts for 7% of U.S. health care greenhouse gas emissions.
  • CHARME fills a critical gap in existing decarbonization initiatives and has the potential to improve emission reductions in activities such as manufacturing and transportation practices across the MedTech supply chain.
  • The CHARME initiative will implement key findings from the white paper Catalyzing Collective Action to Decarbonize Healthcare Roadmap for Health Systems and MedTech Suppliers , which was published in 2023 by Kaiser Permanente, Health Care Without Harm, and Accenture, with input from over 30 organizations.

BD Named a Best Employer for Excellence in Employee Well-Being

Retrieved on: 
Tuesday, April 9, 2024
Well, American Heart Association, Health, Culture, Job satisfaction, Health equity, BDX, Mental health, Cigna, Gold, Workforce, Safety, Management

BD also garnered honors for "Excellence in Global Health & Well-being" for its ability to meet the diverse needs of employees in multiple countries and its commitment to equity, with a set of standard benefits offerings.

Key Points: 
  • BD also garnered honors for "Excellence in Global Health & Well-being" for its ability to meet the diverse needs of employees in multiple countries and its commitment to equity, with a set of standard benefits offerings.
  • "Our integrated approach focuses on physical, emotional, financial and social well-being, and empowers our people to thrive—personally and professionally."
  • This award is the latest accolade for BD employee well-being efforts.
  • Additionally, the American Heart Association awarded BD a Gold level recognition for its commitments to employee health and well-being as measured in the Association's 2023 Well-being Works Better Scorecard.

GHX Celebrates 2023 Millennium Club Honorees for Supply Chain Automation

Retrieved on: 
Tuesday, April 9, 2024
University Health System, Cleveland Clinic, Providence Health & Services, Organization, Ohio State University, New Haven, Connecticut, NYU Langone Health, Health, JW Marriott Hotels, Northwell Health, RWJBarnabas Health, Heart, UnityPoint Health, Summit, Memorial Hermann Health System, Harbor

LOUISVILLE, Colo., April 9, 2024 /PRNewswire/ -- Global Healthcare Exchange (GHX) today proudly named 89 leading healthcare provider and supplier organizations to the 2023 Millennium Club. The Millennium Club honors healthcare organizations that demonstrate their commitment to a digital-first supply chain by automating more than one million transactions annually through the GHX Exchange, an industry leading cloud-based supply chain network. Honorees were selected from more than 5,300 healthcare providers and suppliers in North America who embraced the strong role of digitalization in improving patient care and lowering the cost to deliver it.

Key Points: 
  • LOUISVILLE, Colo., April 9, 2024 /PRNewswire/ -- Global Healthcare Exchange (GHX) today proudly named 89 leading healthcare provider and supplier organizations to the 2023 Millennium Club .
  • The Millennium Club honors healthcare organizations that demonstrate their commitment to a digital-first supply chain by automating more than one million transactions annually through the GHX Exchange, an industry leading cloud-based supply chain network.
  • Millennium Club members will be celebrated at the 2024 GHX Summit taking place May 13-16 at the JW Marriott in Austin, Texas.
  • The 2023 GHX Millennium Club includes:
    Beth Israel Lahey Health (Cambridge, Mass.)

AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture

Retrieved on: 
Thursday, April 4, 2024
Health, Oncology, Cardiology, Medical Devices, Radio, MED, Dialysis, Pulmonary embolism, Growth, Patient, News, Nanoknife, Cancer, Public expenditure, Table, APEX, Quality of life, PICC, Radiofrequency ablation, IP, GAAP, Patent, Starburst, FDA, Medical laboratory scientist, Pharmaceutical industry

Net sales for the third quarter of fiscal year 2024 were $66.0 million, an increase of 8.0% compared to the prior-year quarter.

Key Points: 
  • Net sales for the third quarter of fiscal year 2024 were $66.0 million, an increase of 8.0% compared to the prior-year quarter.
  • U.S. net sales in the third quarter of fiscal 2024 were $55.8 million, an increase of 5.9% from sales of $52.7 million a year ago.
  • GAAP reported gross margin was 47.7%, a decrease of 250 basis points compared to the third quarter of fiscal 2023.
  • On a pro forma basis, gross margin for the third quarter of fiscal 2024 was 51.1%, a decline of 290 basis points from the third quarter of fiscal 2023.

AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.

Retrieved on: 
Monday, April 1, 2024
Legal, Surgery, Medical Devices, Medical Supplies, Health Technology, Professional Services, Cardiology, Health, Oncology, Cancer, C.A, Patent, CAFC

Under the terms of the settlement, BD will grant a license to AngioDynamics under certain of BD’s port patents and AngioDynamics will grant BD a license under certain of AngioDynamics’ catheter patents.

Key Points: 
  • Under the terms of the settlement, BD will grant a license to AngioDynamics under certain of BD’s port patents and AngioDynamics will grant BD a license under certain of AngioDynamics’ catheter patents.
  • AngioDynamics will also make six minimum annual payments to BD of $2.5 million through February 2029, and potential additional payments if six percent (6%) of annual net sales of AngioDynamics’ port products exceed the minimum payment.
  • The parties will participate in the pending appeal before the Federal Circuit of the case titled C.R.
  • Neither party admitted any liability in connection with the settlement agreement.